DRx Choice Childrens Stuffy Nose and Chest Congestion

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: DRx Choice Childrens Stuffy Nose and Chest Congestion
Generic name: GUAIFENESIN AND PHENYLEPHRINE HCL
Manufacturer: RARITAN PHARMACEUTICALS
Product type: HUMAN OTC DRUG
SPL set ID: 7a3bb739-ff50-4d29-b270-d6b084906493
SPL ID: b2f9f84b-eb3a-468b-b6b2-7341e243cd0e
Version: 4
Effective date: 2026-09-09
Source export date: 2026-10-30
Source partition: 2
Source file: https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/57469fe40e5b1c0d9604dc7dbc22532ea48e8e53acfb911fc676578d98492f7e/drug-label-0002-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 18:30:10

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M012	openfda.application_number
brand name		DRx Choice Childrens Stuffy Nose and Chest Congestion	openfda.brand_name
generic name		GUAIFENESIN AND PHENYLEPHRINE HCL	openfda.generic_name
manufacturer name		RARITAN PHARMACEUTICALS	openfda.manufacturer_name
ndc	package	68163-748-04	openfda.package_ndc
ndc	product	68163-748	openfda.product_ndc
ndc11	package	68163074804	derived:openfda.package_ndc
rxcui		1485599	openfda.rxcui
spl id		b2f9f84b-eb3a-468b-b6b2-7341e243cd0e	id
spl set id		7a3bb739-ff50-4d29-b270-d6b084906493	set_id
unii		04JA59TNSJ	openfda.unii
unii		495W7451VQ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child’s prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.